Mason C
Regenerative Medicine Bioprocessing Unit, Advanced Centre for Biochemical Engineering, University College London, UK.
Med Device Technol. 2007 Mar-Apr;18(2):25-30.
The regenerative medicine industry has moved into a new era in which commercialisation and not research is the number one priority. To achieve its new goal, much has had to change, including the introduction of expert business management, simpler but superior products and scalability of manufacture. Mass public and political support is supplying both long-term resources and the market demand to finally create a sustainable new health-care sector.
再生医学产业已步入一个新时代,在这个时代,商业化而非研究成为首要任务。为实现新目标,诸多方面必须做出改变,包括引入专业的商业管理、更简单却更优质的产品以及制造的可扩展性。公众和政治层面的广泛支持正在提供长期资源和市场需求,最终打造出一个可持续的新医疗保健领域。